(Q28741833)

2 November 2019

Neisseria meningitidis

1 reference

2 November 2019

meningococcal vaccine

1 reference

24 January 2021

3

0 references

Lina Zgaga

5

0 references

Igor Rudan

14

Igor Rudan

0 references

Harish Nair

4

Harish Nair

0 references

Ray Borrow

12

Ray Borrow

0 references

Harry Campbell

13

Harry Campbell

0 references

Shams Arifeen

10

Shams El Arifeen

0 references

Tanvir M Huda

2

Tanvir Huda

0 references

Jian Shayne F Zhang

9

Jian Shayne F Zhang

0 references

Hope L Johnson

8

Hope L Johnson

0 references

Debajeet Choudhuri

1

Debajeet Choudhuri

0 references

Rachel Falconer

6

Rachel Falconer

0 references

author name string

Ivana Luksic

7

0 references

Christopher B Nelson

Creative Commons Attribution 2.0 Generic

11

0 references

language of work or name

English

0 references

publication date

13 April 2011

8 references

23 March 2019

25 April 2019

20 June 2019

2 November 2019

24 January 2021

27 May 2022

28 November 2023

10 January 2024

8 references

23 March 2019

25 April 2019

20 June 2019

2 November 2019

24 January 2021

27 May 2022

28 November 2023

10 January 2024

11 Suppl 3

0 references

issue

Suppl 3

0 references

page(s)

S29

0 references

copyright license

8 references

23 March 2019

25 April 2019

20 June 2019

2 November 2019

24 January 2021

27 May 2022

28 November 2023

on focus list of Wikimedia project

10 January 2024

copyright status

copyrighted

0 references

ScienceSource

0 references

cites work

Prevention and control of meningococcal disease. Recommendations of the Advisory Committee on Immunization Practices (ACIP)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3231902

Decline in Invasive Pneumococcal Disease after the Introduction of Protein–Polysaccharide Conjugate Vaccine

17 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3231902

Advances in the development of vaccines against Neisseria meningitidis

17 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3231902

The Elimination of Haemophilus influenzae type b meningitis following conjugate vaccine introduction in Senegal

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3231902

Quadrivalent meningococcal vaccination of adults: phase III comparison of an investigational conjugate vaccine, MenACWY-CRM, with the licensed vaccine, Menactra

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3231902

Setting priorities for global mental health research

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3231902

Quadrivalent meningococcal conjugate vaccines.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3231902

Phase III comparison of an investigational quadrivalent meningococcal conjugate vaccine with the licensed meningococcal ACWY conjugate vaccine in adolescents

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3231902

Setting research priorities to reduce global mortality from childhood diarrhoea by 2015.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3231902

Immunogenicity and immune memory of a nonadjuvanted quadrivalent meningococcal glycoconjugate vaccine in infants

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3231902

Incremental system costs of introducing combined DTwP-hepatitis B-Hib vaccine into national immunization services in Ethiopia

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3231902

Prospects and challenges with introduction of a mono-valent meningococcal conjugate vaccine in Africa

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3231902

Setting priorities in global child health research investments: guidelines for implementation of CHNRI method

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3231902

Setting priorities in global child health research investments: universal challenges and conceptual framework

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3231902

A phase II, randomized study on an investigational DTPw-HBV/Hib-MenAC conjugate vaccine administered to infants in Northern Ghana

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3231902

Meningococcal carriage in the African meningitis belt

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3231902

The development of a new heptavalent diphtheria-tetanus-whole cell pertussis-hepatitis B-Haemophilus influenzae type b-Neisseria meningitidis serogroups A and C vaccine: a randomized dose-ranging trial of the conjugate vaccine components

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3231902

Setting priorities in global child health research investments: addressing values of stakeholders

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3231902

Setting priorities in child health research investments for South Africa

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3231902

An economic evaluation of thermostable vaccines in Cambodia, Ghana and Bangladesh

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3231902

Meningitis serogroup W135 outbreak, Burkina Faso, 2002

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3231902

The promise of conjugate vaccines for Africa

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3231902

Conquering the meningococcus

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3231902

A review of vaccine research and development: meningococcal disease

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3231902

Immunogenicity of meningococcal ACYW135 polysaccharide vaccine in Saudi children 5 to 9 years of age.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3231902

Recent developments in Neisseria meningitidis group A conjugate vaccines

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3231902

Herd immunity from meningococcal serogroup C conjugate vaccination in England: database analysis

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3231902

Emergency vaccination against epidemic meningitis in Ghana: Implications for the control of meningococcal disease in West Africa

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3231902

Meningococcal carriage, meningococcal disease and vaccination

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3231902

Production and control of Neisseria meningitidis vaccines

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3231902

Meningococcal disease and prevention at the Hajj.

3 June 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2458-11-S3-S29

W135 meningococcal carriage in association with the Hajj pilgrimage 2001: the Singapore experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2458-11-S3-S29

Effectiveness of a trivalent serogroup A/C/W135 meningococcal polysaccharide vaccine in Burkina Faso, 2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2458-11-S3-S29

Carriage of serogroup C meningococci 1 year after meningococcal C conjugate polysaccharide vaccination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2458-11-S3-S29

Safety, immunogenicity, and immune memory of a novel meningococcal (groups A, C, Y, and W-135) polysaccharide diphtheria toxoid conjugate vaccine (MCV-4) in healthy adolescents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2458-11-S3-S29

Research Priorities to Reduce Global Mortality From Newborn Infections by 2015

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2458-11-S3-S29

Safety and Immunogenicity of a Tetravalent Polysaccharide Vaccine Against Meningococcal Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2458-11-S3-S29

Co-coverage of preventive interventions and implications for child-survival strategies: evidence from national surveys

21 January 2018

2 references

https://api.crossref.org/works/10.1186%2F1471-2458-11-S3-S29

21 January 2018

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3231902

Childhood pneumonia and diarrhoea: setting our priorities right

27 November 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2458-11-S3-S29

Immunogenicity and reactogenicity of a booster dose of a novel combined Haemophilus influenzae type b-Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine given to toddlers of 13-14 months of age with antibody persistence up to 31 mont

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2458-11-S3-S29

Research priorities for health of people with disabilities: an expert opinion exercise

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2458-11-S3-S29

Infectious disease. Hitting early, epidemic meningitis ravages Nigeria and Niger.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3231902

Setting priorities in global child health research investments: assessment of principles and practice

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3231902

Positive effect of the introduction of Haemophilus influenzae type b vaccination in the expanded program on immunization in Cameroon

27 November 2018

1 reference

12 December 2020

Epidemics of meningococcal disease. African meningitis belt, 2001

1 reference

12 December 2020

Meningococcal conjugate vaccine for Africa: a model for development of new vaccines for the poorest countries

1 reference

12 December 2020

The Meningitis Vaccine Project

1 reference

12 December 2020

Safety, immunogenicity, and antibody persistence of a new meningococcal group A conjugate vaccine in healthy Indian adults

1 reference

12 December 2020

Immunogenicity, reactogenicity and persistence of meningococcal A, C, W-135 and Y-tetanus toxoid candidate conjugate (MenACWY-TT) vaccine formulations in adolescents aged 15–25 years

1 reference

12 December 2020

The complex challenge of setting priorities in health research investments

1 reference

12 December 2020

A dose-range study assessing immunogenicity and safety of one dose of a new candidate meningococcal serogroups A, C, W-135, Y tetanus toxoid conjugate (MenACWY-TT) vaccine administered in the second year of life and in young children

1 reference

12 December 2020

Efficacy of meningococcal serogroup C conjugate vaccine in teenagers and toddlers in England

1 reference

12 December 2020